SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-00-001562
Filing Date
2000-01-18
Accepted
2000-01-18 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A SC 13D/A 16715
2 EXHIBIT 99.1A EX-99.1A 1487
3 EXHIBIT 99.1B EX-99.1B 1636
  Complete submission text file 0000912057-00-001562.txt   22142
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 505 COAST BLVD SOUTH SUITE 300 LA JOLLA CA 92037
Business Address 505 COAST BLVD SOUTH STE 300 LA JOLLA CA 92037 6194525892
SIBIA NEUROSCIENCES INC (Subject) CIK: 0001011065 (see all company filings)

IRS No.: 953616229 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48087 | Film No.: 509060
SIC: 2834 Pharmaceutical Preparations